EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,466 | -79.8% | 410 | -75.2% | 0.00% | – |
| Q2 2023 | $32,076 | +267200.0% | 1,650 | +302.4% | 0.00% | – |
| Q1 2023 | $12 | 0.0% | 410 | 0.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 410 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -51.9% | 410 | -33.5% | 0.00% | – |
| Q2 2022 | $27,000 | 0.0% | 617 | +12.8% | 0.00% | – |
| Q1 2022 | $27,000 | -81.0% | 547 | -82.3% | 0.00% | -100.0% |
| Q4 2021 | $142,000 | -16.0% | 3,085 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $169,000 | -11.5% | 3,035 | -32.1% | 0.00% | 0.0% |
| Q2 2021 | $191,000 | -16.2% | 4,472 | -18.3% | 0.00% | 0.0% |
| Q1 2021 | $228,000 | -10.6% | 5,472 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $255,000 | +152.5% | 5,472 | +130.5% | 0.00% | +100.0% |
| Q3 2020 | $101,000 | – | 2,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |